[Renal microscopic polyarteritis replaced by pericarditis with episodic increases in MPO-ANCA in a patient with

K Tomori1, H Okada, H Nemoto

  • 1Department of Nephrology, Saitama Medical College, Japan.

Nihon Jinzo Gakkai Shi
|January 20, 1999
PubMed

Insights

This case highlights that myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) may indicate systemic lupus erythematosus (SLE) activity, not just microscopic polyarteritis. Careful evaluation is crucial for MPO-ANCA in SLE patients.

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunology

Background:

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
  • Microscopic polyarteritis is a vasculitis often associated with MPO-ANCA.
  • Distinguishing the specific autoimmune activity indicated by MPO-ANCA in complex cases is clinically important.

Observation:

  • A patient presented with acute renal failure, diagnosed as MPO-ANCA-associated microscopic polyarteritis, but underlying SLE was identified.
  • Initial treatment with prednisolone and cyclophosphamide improved renal function and lowered MPO-ANCA titers.
  • Recurrence of symptoms, including pericarditis and pleural effusion, coincided with rising MPO-ANCA levels, despite minimal renal biopsy abnormalities.

Findings:

  • MPO-ANCA titers correlated with SLE activity (pericarditis) rather than active polyarteritis.
  • Successful treatment of SLE manifestations led to a decrease in MPO-ANCA levels.
  • The patient's renal injury and polyarteritis were attributed to SLE.

Implications:

  • MPO-ANCA may serve as a marker for SLE activity, particularly in patients with overlapping features of vasculitis.
  • Clinical interpretation of MPO-ANCA requires careful consideration of the full clinical picture in SLE patients.
  • This case underscores the complexity of ANCA-associated vasculitis in the context of SLE.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...